Source:http://linkedlifedata.com/resource/pubmed/id/11967251
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2002-4-22
|
pubmed:abstractText |
Elevations in the serum concentration of the carboxy-terminal propeptide of procollagen type I (PIP) >127 microg/L have been found to predict severe myocardial fibrosis in hypertensive patients. This study was designed to assess whether ultrasonic reflectivity, evaluated by a real-time integrated backscatter analysis, was related to the severity of myocardial fibrosis as estimated by serum PIP. Thirty-four subjects were included in the study. Serum PIP was measured by specific radio immunoanalysis. Backscatter cyclic variation and maximal intensity were measured in 6 regions throughout the left ventricle. The subjects were divided into 3 groups: 14 normotensives with PIP <127 microg/L (group 1), 12 hypertensives with PIP <127 microg/L (group 2), and 8 hypertensives with PIP >127 microg/L (group 3). The highest cyclic variation was found in group 1 and the lowest in group 3 (5.78+/-0.25 versus 4.70+/-0.33 dB, P<0.05), with intermediate values in group 2 (5.10+/-0.27 dB). No differences in maximal intensity were found among the 3 groups of subjects. Using receiver operating characteristics curves, we observed that a cutoff of 2.90 dB for cyclic variation measured in the apex provided 75% sensitivity and 63% specificity for predicting PIP >127 microg/L in hypertensives, with a relative risk of 2.50 (95% CI, 0.72 to 34.70). These results show an association between diminished cyclic variation of backscatter and increased serum concentration of PIP in hypertension. Thus, the combination of these 2 parameters may be useful for the diagnosis of severe myocardial fibrosis associated with hypertension.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1524-4563
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
923-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11967251-Adult,
pubmed-meshheading:11967251-Aged,
pubmed-meshheading:11967251-Biological Markers,
pubmed-meshheading:11967251-Cardiomyopathies,
pubmed-meshheading:11967251-Echocardiography,
pubmed-meshheading:11967251-Female,
pubmed-meshheading:11967251-Fibrosis,
pubmed-meshheading:11967251-Humans,
pubmed-meshheading:11967251-Hypertension,
pubmed-meshheading:11967251-Hypertrophy, Left Ventricular,
pubmed-meshheading:11967251-Male,
pubmed-meshheading:11967251-Middle Aged,
pubmed-meshheading:11967251-Peptide Fragments,
pubmed-meshheading:11967251-Procollagen,
pubmed-meshheading:11967251-ROC Curve,
pubmed-meshheading:11967251-Ventricular Dysfunction, Left
|
pubmed:year |
2002
|
pubmed:articleTitle |
Ultrasonic backscatter and serum marker of cardiac fibrosis in hypertensives.
|
pubmed:affiliation |
Department of Cardiology and Cardiovascular Surgery, University Clinic of Navarra, University of Navarra, Pamplona, Spain.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|